Landfar Bio medicine Co

Landfar Bio medicine Co Quick Ratio

The Quick Ratio (Acid Test) of Landfar Bio medicine Co (000504.SZ) as of Oct 16, 2026 is 0.72. In the previous year, Quick Ratio (Acid Test) was 1.15 — a change of -37.93% (lower).

Quick Ratio

0.72

YoY

-37.93%

Last updated:

Quick Ratio (Acid Test) of Landfar Bio medicine Co is 2025 0.72 . Quick Ratio (Acid Test) of Landfar Bio medicine Co was 2024 1.15 . It decreases by -37.93% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Landfar Bio medicine Co Stock analysis

What does Landfar Bio medicine Co do? Landfar Bio medicine Co Ltd, listed on the Shenzhen Stock Exchange under ticker 000504.SZ, operates as a biotechnology company based in Changsha, China. The company went public on December 8, 1992, and currently employs 512 people. Its primary business activities include the manufacture and sale of pharmaceutical products, with a focus on biomedical services such as stem cell storage, technical services, and research into stem cell treatments. Additionally, the company engages in medical instrument purchasing and sales. Landfar Bio medicine also operates within the energy conservation and environmental protection sector, offering services like contract energy management through energy management companies (EMCs), build-transfer (BT) projects, product sales, and sewage treatment solutions. The firm primarily serves the domestic Chinese market, with no indication of significant international operations. Its official website is http://www.nhbiogroup.com/, though the source description provided contains conflicting information referring to the company as NanHua Bio-medicine Co., Ltd., which may be an error or an alternate name. The company’s industry classification is biotechnology within the healthcare sector, reflecting its focus on innovative medical solutions and environmental sustainability initiatives. Landfar Bio medicine Co Ltd maintains a presence in Changsha, Hunan, and its operations are centered around pharmaceuticals, biomedical services, and environmental technologies. Landfar Bio medicine Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Landfar Bio medicine Co stock

Quick Ratio (Acid Test) of Landfar Bio medicine Co is 0.72 in 2025.

Quick Ratio (Acid Test) of Landfar Bio medicine Co changed from 1.15 to 0.72, representing a -37.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Landfar Bio medicine Co since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Landfar Bio medicine Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Landfar Bio medicine Co

All Key Metrics — Landfar Bio medicine Co